Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
71 /100
HIGH RISK
Score updated Aug 28, 2026

INM — InMed Pharmaceuticals Inc. Dilution Risk Tracker

Track INM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INM — Get alerts when the score changes →

As of August 28, 2026, InMed Pharmaceuticals Inc. (INM) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. InMed Pharmaceuticals Inc. has a market capitalization of $5.20M, 3.31M shares outstanding. Stored dilution-related fields include shelf registration capacity of $50.00M, ATM program capacity of $1.21M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 50%
🔄 Reverse Split model est. 65%
• 50-day avg $0.85 below $1 exchange minimum
• 8 months cash with weak price
💰 Capital Raise model 53%
• Under 12 months cash (8mo)
• Active shelf registration ($50M, 961% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (71/100)
🔔 Track INM — Get forecast alerts →

Market Data

Market Cap$5.20M
Shares Outstanding3.31M
Float1.97M
Cash$5.20M
Debt$29.3K
Short InterestN/A

Institutional Holdings

71.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track INM for full holder detail →

Short Interest

Short Interest83.1K
Days to Cover1.0
% of Float4.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-06-30
8-K 8K EVENT 2026-04-27
424B5 ATM 2026-04-03
EFFECT EFFECT 2026-03-30
S-3 SHELF 2026-03-20
Full SEC filing analysis available with free account

Recent News

No recent news

Factual INM Dilution Snapshot

InMed Pharmaceuticals Inc. (INM) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track INM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INM
INM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.